Get the Stockscreener App
3.3244
27.96%
-1.3256
Lipella Pharmaceuticals Inc Stock (LIPO) Forecast
The Lipella Pharmaceuticals Inc (LIPO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.1888, representing a -94.32% decrease from the current price of $3.3244. The highest analyst price target is $0.3695, and the lowest is $0.00816.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LIPO Price Target
Average 0.5723
(-82.79% Downside)
Is Lipella Pharmaceuticals Inc (LIPO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.50 | Neutral |
| STOCH(9,6) | 25.59 | Neutral |
| STOCHRSI(14) | 41.50 | Neutral |
| MACD(12,26) | 0.0841 | Buy |
| ADX(14) | 21.29 | Neutral |
| William %R | -82.33 | Buy |
| CCI(14) | 99.30 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.937
Buy
|
3.1126
Buy
|
| MA20 |
2.9303
Buy
|
3.0098
Buy
|
| MA50 |
2.9518
Buy
|
2.9938
Buy
|
| MA100 |
3.0786
Buy
|
3.2179
Buy
|
| MA200 |
3.8359
Sell
|
4.1615
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, LIPO could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on LIPO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.5 indicates that LIPO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.59 indicates that LIPO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 41.5 indicates that LIPO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.29 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 99.3 indicates that LIPO is still overbought but not to an extreme extent.
Long-term LIPO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lipella Pharmaceuticals Inc financial reports and earnings history, Lipella Pharmaceuticals Inc (LIPO) stock could reach $4.1438 by 2030, $18.70 by 2040 and $15.92 by 2050. See the projected annual prices until 2050 of the Lipella Pharmaceuticals Inc stock below:
- Lipella Pharmaceuticals Inc (LIPO) is expected to reach an average price of $10.16 in 2035, with a high prediction of $10.90 and a low estimate of $10.35. This indicates an $205.73% rise from the last recorded price of $3.3244.
- Lipella Pharmaceuticals Inc (LIPO) stock is projected to chart a bullish course in 2040, with an average price target of $18.53, representing an $457.51% surge from its current level. The forecast ranges from a conservative $18.67 to a sky-high $18.70.
- Our analysts predict Lipella Pharmaceuticals Inc (LIPO) to jump 177.50% by 2045, soaring from $9.2302 to an average price of $9.2252, potentially reaching $9.6419. While $9.2302 is the low estimate, the potential upside is significant.
- Lipella Pharmaceuticals Inc (LIPO) stock is expected to climb by 2050, reaching an average of $15.02, a $351.90% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.92 and $15.10, respectively, highlighting the market's uncertainty.
Lipella Pharmaceuticals Inc Stock (LIPO) Year by Year Forecast
Lipella Pharmaceuticals Inc Stock (LIPO) Price Forecast for 2025
Lipella Pharmaceuticals Inc Stock (LIPO) is expected to reach an average price of $0.8218 in 2025, with a high prediction of $1.642 and a low estimate of $0.00162. This indicates an -75.28% fall from the last recorded price of $3.3244.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.1514 | $0.00816 | $0.3695 | -95.45% |
| April, 2025 | $0.2145 | $0.088 | $0.3045 | -93.55% |
| May, 2025 | $0.2909 | $0.1877 | $0.3108 | -91.25% |
| June, 2025 | $0.1272 | $0.00162 | $0.6308 | -96.17% |
| July, 2025 | $0.1484 | $0.0372 | $0.254 | -95.54% |
| August, 2025 | $0.9058 | $0.1471 | $0.3359 | -72.75% |
| September, 2025 | $1.3029 | $1.1925 | $1.1429 | -60.81% |
| October, 2025 | $1.0767 | $1.1967 | $1.0632 | -67.61% |
| November, 2025 | $0.9238 | $0.9688 | $1.0035 | -72.21% |
| December, 2025 | $0.6377 | $0.6509 | $0.5941 | -80.82% |
Lipella Pharmaceuticals Inc Stock (LIPO) Price Forecast for 2026
The predicted value for Lipella Pharmaceuticals Inc (LIPO) in 2026 is set at an average of $1.5032. Estimates vary from a peak of $2.7023 to a trough of $0.3041, indicating an -54.78% surge from the present price of $3.3244.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.4847 | $0.538 | $0.4844 | -85.42% |
| February, 2026 | $0.4018 | $0.4518 | $0.3915 | -87.91% |
| March, 2026 | $0.4189 | $0.3041 | $0.2089 | -87.40% |
| April, 2026 | $0.8528 | $0.7356 | $1.0012 | -74.35% |
| May, 2026 | $0.8298 | $0.9295 | $0.7995 | -75.04% |
| June, 2026 | $0.7969 | $0.7861 | $0.7466 | -76.03% |
| July, 2026 | $0.6108 | $0.7107 | $0.7705 | -81.63% |
| August, 2026 | $0.4878 | $0.5634 | $0.5176 | -85.33% |
| September, 2026 | $0.3217 | $0.3503 | $0.4896 | -90.32% |
| October, 2026 | $0.5538 | $0.5469 | $0.5052 | -83.34% |
| November, 2026 | $0.3949 | $0.4059 | $0.4955 | -88.12% |
| December, 2026 | $2.849 | $0.3273 | $2.7023 | -14.30% |
Lipella Pharmaceuticals Inc Stock (LIPO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lipella Pharmaceuticals Inc (LIPO) is $1.9832, with a high forecast of $2.7093 and a low forecast of $1.2571. This indicates an -40.34% decrease from the last price of $3.3244.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.1596 | $2.7946 | $2.7093 | -35.04% |
| February, 2027 | $2.5603 | $2.6801 | $2.5631 | -22.99% |
| March, 2027 | $2.161 | $2.161 | $2.3504 | -34.99% |
| April, 2027 | $1.9018 | $1.9516 | $1.9612 | -42.79% |
| May, 2027 | $1.7023 | $1.7523 | $1.762 | -48.79% |
| June, 2027 | $1.3603 | $1.5528 | $1.5917 | -59.08% |
| July, 2027 | $2.1432 | $1.4552 | $1.5435 | -35.53% |
| August, 2027 | $1.9743 | $2.0419 | $2.0858 | -40.61% |
| September, 2027 | $1.7251 | $1.8362 | $1.7944 | -48.11% |
| October, 2027 | $1.7257 | $1.7212 | $1.6557 | -48.09% |
| November, 2027 | $1.4963 | $1.5163 | $1.5358 | -54.99% |
| December, 2027 | $1.2071 | $1.2571 | $1.3065 | -63.69% |
Lipella Pharmaceuticals Inc Stock (LIPO) Price Forecast for 2028
In 2028, Lipella Pharmaceuticals Inc (LIPO) is projected to reach an average price of $2.5745, with a high projection of $4.302 and a low estimate of $0.847. This indicates an -22.56% fall from the last price of $3.3244.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.3288 | $1.0361 | $1.1273 | -60.03% |
| February, 2028 | $1.1038 | $1.1683 | $1.1579 | -66.80% |
| March, 2028 | $0.9227 | $0.847 | $0.9985 | -72.24% |
| April, 2028 | $4.5322 | $4.425 | $4.302 | +36.33% |
| May, 2028 | $4.1505 | $4.2399 | $4.2758 | +24.85% |
| June, 2028 | $3.7941 | $3.8541 | $3.994 | +14.13% |
| July, 2028 | $3.3282 | $3.5182 | $3.6676 | +0.12% |
| August, 2028 | $3.1059 | $3.1059 | $3.2118 | -6.57% |
| September, 2028 | $2.8301 | $2.9865 | $2.9295 | -14.87% |
| October, 2028 | $2.5843 | $2.6063 | $2.5672 | -22.26% |
| November, 2028 | $2.182 | $2.6878 | $3.1704 | -34.36% |
| December, 2028 | $2.8761 | $2.9361 | $2.8691 | -13.48% |
Lipella Pharmaceuticals Inc Stock (LIPO) Price Forecast for 2029
The 2029 price forecast for Lipella Pharmaceuticals Inc Stock (LIPO) is $3.6342 on average, with a high prediction of $5.9017 and a low estimate of $1.3667. This represents an +9.32% increase from the previous price of $3.3244.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6338 | $2.6563 | $2.6897 | -20.77% |
| February, 2029 | $2.388 | $2.468 | $2.5409 | -28.17% |
| March, 2029 | $2.1422 | $2.2021 | $2.2715 | -35.56% |
| April, 2029 | $1.8663 | $1.9162 | $2.0057 | -43.86% |
| May, 2029 | $1.774 | $1.722 | $1.8105 | -46.64% |
| June, 2029 | $1.5603 | $1.6012 | $1.7077 | -53.07% |
| July, 2029 | $5.8045 | $1.3667 | $5.2346 | +74.60% |
| August, 2029 | $5.7291 | $5.9091 | $5.9017 | +72.34% |
| September, 2029 | $5.5268 | $5.6468 | $5.5631 | +66.25% |
| October, 2029 | $4.8115 | $5.1015 | $5.4038 | +44.73% |
| November, 2029 | $4.6392 | $4.7022 | $4.7384 | +39.55% |
| December, 2029 | $4.2869 | $4.3899 | $4.4361 | +28.95% |
Lipella Pharmaceuticals Inc Stock (LIPO) Price Forecast for 2030
Lipella Pharmaceuticals Inc Stock (LIPO) is expected to reach an average price of $4.6939 in 2030, with a high forecast of $7.5013 and a low forecast of $1.8864. This signifies an +41.19% surge from the last price of $3.3244.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.7915 | $3.9214 | $4.1438 | +14.05% |
| February, 2030 | $4.0891 | $3.7573 | $3.7792 | +23.00% |
| March, 2030 | $4.0069 | $4.1769 | $4.255 | +20.53% |
| April, 2030 | $3.7846 | $3.8843 | $3.9038 | +13.84% |
| May, 2030 | $3.5992 | $3.5914 | $3.6515 | +8.27% |
| June, 2030 | $3.1169 | $3.2168 | $3.4261 | -6.24% |
| July, 2030 | $2.7615 | $2.8215 | $2.9739 | -16.93% |
| August, 2030 | $2.3792 | $2.4078 | $2.6385 | -28.43% |
| September, 2030 | $2.4119 | $2.4169 | $2.4631 | -27.45% |
| October, 2030 | $1.9537 | $1.9715 | $2.3039 | -41.23% |
| November, 2030 | $7.648 | $1.8864 | $7.5013 | +130.06% |
| December, 2030 | $6.7593 | $7.3943 | $7.4086 | +103.32% |
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):